Inventor · disambiguated record
Carla De Faveri
Also filed as: DE FAVERI CARLA
21 granted patents·4 pending applications·46 citations·filing 2004–2025
92Inventor score
Files withLUNDBECK PHARMACEUTICALS ITALY S P A6LUNDBECK & CO AS H4H LUNDBECK AS3ALFASIGMA SPA2ALLERGAN INC2
Top patents by PatentIndex Score
25 records- 0196US12234235B2Salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersALFASIGMA SPA·Filed 2023·Granted Feb 25, 2025·2 cites·4 claims
- 0293US9382247B2Salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2015·Granted Jul 5, 2016·12 cites·2 claims
- 0389US10894778B2Method for the manufacturing of delmopinolLUNDBECK PHARMACEUTICALS ITALY S P A·Filed 2017·Granted Jan 19, 2021·3 cites·20 claims
- 0482US10717747B2Method for the manufacturing of 2-(3-(alkyl and alkenyl)morpholino)-ethan-1-olsLUNDBECK PHARMACEUTICALS ITALY S P A·Filed 2017·Granted Jul 21, 2020·2 cites·16 claims
- 0581US10815251B2Method for the manufacturing of 2-(3-(alkyl and alkenyl)morpholino)-ethan-1-olsLUNDBECK PHARMACEUTICALS ITALY S P A·Filed 2020·Granted Oct 27, 2020·1 cites·4 claims
- 0680US8530495B2Nalmefene hydrochloride dihydrateLOPEZ DE DIEGO HEIDI·Filed 2009·Granted Sep 10, 2013·4 cites·15 claims
- 0778US10626123B2Manufacture of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-olH LUNDBECK AS·Filed 2016·Granted Apr 21, 2020·1 cites·8 claims
- 0876US2025289816A1Salts and pharmacutical compositions thereof for the treatment of inflammatory disordersALFASIGMA SPA·Filed 2025·Application pending·0 cites
- 0971US11578043B2Salt of delmopinolLUNDBECK PHARMACEUTICALS ITALY S P A·Filed 2018·Granted Feb 14, 2023·0 cites·19 claims
- 1070US8754217B2Nalmefene hydrochloride dihydrateLUNDBECK & CO AS H·Filed 2013·Granted Jun 17, 2014·1 cites·28 claims
- 1169US9242935B2(-)-(2R,3S)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (L)-(+) tartrate salt, its method of production and useALLERGAN INC·Filed 2014·Granted Jan 26, 2016·1 cites·15 claims
- 1269US8598352B2Preparation of nalmefene hydrochloride from naltrexoneDE FAVERI CARLA·Filed 2010·Granted Dec 3, 2013·6 cites·20 claims
- 1369US7531694B2Process for synthesis of 4-4′-diamino-diphenyl-sulfoneLUNDBECK PHARMACEUTICALS ITALY·Filed 2004·Granted May 12, 2009·11 cites·9 claims
- 1468US11332478B2Manufacture of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-olH LUNDBECK AS·Filed 2020·Granted May 17, 2022·0 cites·13 claims
- 1568US8841452B1Process for recovery of nalmefene hydrochlorideLUNDBECK & CO AS H·Filed 2012·Granted Sep 23, 2014·1 cites·19 claims
- 1660US8436209B2Process for the manufacture of memantine and intermediate productHUBER FLORIAN ANTON MARTIN·Filed 2009·Granted May 7, 2013·1 cites·14 claims
- 1760US2016376269A1Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersSABOURAULT NICOLAS LUC·Filed 2016·Application pending·0 cites
- 1854US11384056B2Method for the manufacturing of delmopinol intermediatesLUNDBECK PHARMACEUTICALS ITALY S P A·Filed 2017·Granted Jul 12, 2022·0 cites·19 claims
- 1954US8022232B2Method for manufacture of escitalopramLUNDBECK & CO AS H·Filed 2008·Granted Sep 20, 2011·0 cites·22 claims
- 2051US8580963B2Method for the manufacturing of naltrexoneDE FAVERI CARLA·Filed 2011·Granted Nov 12, 2013·0 cites·13 claims
- 2147US9540328B2(−)-(2R,3S)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (L)-(+) tartrate salt, its method of production and useALLERGAN INC·Filed 2015·Granted Jan 10, 2017·0 cites·11 claims
- 2244US2021147366A1Process for preparation of 2,2-dimethylpiperazineH LUNDBECK AS·Filed 2019·Application pending·0 cites
- 2344US2014155608A1Method for the manufacturing of naltrexoneLUNDBECK & CO AS H·Filed 2013·Application pending·0 cites
- 2438US10329264B2Process for the preparation of isocarboxazidLUNDBECK PHARMACEUTICALS ITALY S P A·Filed 2016·Granted Jun 25, 2019·0 cites·15 claims
- 2537US8912360B2Methods for preparing ritodrine hydrochlorideZANON JACOPO·Filed 2011·Granted Dec 16, 2014·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →